Home > Analytics > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524731     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 30,2022
Price(EOD): ₹ 544.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 250.24 Cr
Value of ₹ 1 Lac invested in JENBURKT PHARMACEUTICALS
on Oct 03,2017 (price: ₹ 455.20)

₹ 1 L

₹ 1.20 L

1W : -1.6% 1M : -9% 1Y : 10.6%
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results
JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
JENBURKT PHARMACEUTICALS -1.6% -9% 10.6%
SUN PHARMACEUTICAL INDUSTRIES 5.8% 8.9% 19.4%
DIVIS LABORATORIES 0.4% 2.4% -27.6%
DR REDDYS LABORATORIES 4.9% 3.1% -9.1%
CIPLA 4.7% 9% 14.9%
GLAND PHARMA 1.5% -16.4% -43.2%
PIRAMAL ENTERPRISES -2.9% -16% -68.6%
CADILA HEALTHCARE 8.6% 3.8% -29.6%
TORRENT PHARMACEUTICALS 3% 1.5% -0.4%

FUNDAMENTAL ANALYSIS OF JENBURKT PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF JENBURKT PHARMACEUTICALS

 
Valuation Score
[As on : Sep 30,2022 ]

Ratio Standalone
P/E
P/B
P/S
10.58
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 23.60 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

2.13
P/B Calculated based on Book Value of Rs 117.38 Cr
[Latest Year - Mar2022 - Standalone Results ]

1.95
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF JENBURKT PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
35%
93%
243%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF JENBURKT PHARMACEUTICALS



JENBURKT PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF JENBURKT PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.05
0.04
0.04
0.04
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF JENBURKT PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF JENBURKT PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.05%
56.34%
47.85%
72.65%
14.54%
35.69%
29.49%
27.99%
QtrlyTrend
8
Latest Qtr: Jun2022
Quarterly Result Analysis →

Insights 💡 JENBURKT PHARMACEUTICALS is one of the top 38% companies with good quarterly result uptrend ! Discover More →

JENBURKT PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about JENBURKT PHARMACEUTICALS


Is JENBURKT PHARMACEUTICALS good for long term investment?

As on Sep 30,2022, the Fundamentals of JENBURKT PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of JENBURKT PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is JENBURKT PHARMACEUTICALS UnderValued or OverValued?

As on Sep 30,2022, JENBURKT PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of JENBURKT PHARMACEUTICALS ?

As on Sep 30,2022, the Intrinsic Value of JENBURKT PHARMACEUTICALS is Rs. 281.91 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 404.37
Fair Value [Median EV / Sales Model] : Rs. 281.91
Fair Value [Median Price / Sales Model] : Rs. 158.52
Estimated Median Fair Value of JENBURKT PHARMACEUTICALS : Rs. 281.91

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is JENBURKT PHARMACEUTICALS trading at a Premium or Discount?

As on Sep 30,2022, JENBURKT PHARMACEUTICALS is trading at a Premium of 93% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].